Prof Greg O'Grady is a Professor of Surgery and the CEO of Alimetry, a New Zealand-based MedTech company developing a device for the non-invasive diagnosis of gastric disorders, such as neuromuscular dysfunction, Gut-brain disorder, Gastric Outlet Disease, to name a few.

Greg's career is truly impressive, and with each rung he has climbed, the scale of the impact he can effect has increased. As a doctor & surgeon, he had the ability to improve the lives of one patient at a time. As a Researcher involved in the development of new techniques or procedures, he could improve the lives of more patients as those improvements were passed on to to other physicians & surgeons. As a Professor, he contributed to the education of the next generation of physicians, who would in turn improve the lives of their patients. But as the an Entrepreneur and CEO responsible for the development of a new medical technology that could improve the lives of as much as 10% of population, the scale of potential impact is unparalleled. It is the ultimate manifestation of the Hippocratic Oath of doing the most good, with the least harm.

Join us in Episode 6 where Greg and I discuss what drove his career pivot from surgeon and surgical/medical research to commercialization, the scale of the problems that Alimetry's device is attempting to solve, why the Healthcare System has a so-called "immune-system" against the adoption of new technologies....and why this is a good thing...and much much more.

You can find out more about Greg and Alimetry here:
https://www.linkedin.com/in/greg-o-grady-b9520353/
https://www.linkedin.com/company/alimetry-ltd/
https://www.alimetry.com/

#medicine #surgery #surgeon #medical device #research #clinicaltrials #clinicalresearch #podcast #podcasts #medicine #healthcare #medicalresearch #venturecapital #startup #startups #entrepreneur #entrepreneurship #hippocrates